Innovations Spotlight

For media inquiries, please contact Susan Bernat – 216.312.4369

At The Heart of Innovation: Q&A w/ Cardiovascular Thought Leaders – Dan Cantillon, MD

02/01/2021

At The Heart of Innovation: Q&A w/ Cardiovascular Thought Leaders – Dan Cantillon, MD

An electrophysiologist by trade, Dr. Cantillon deals with the electrical impulses in the heart and works to diagnose and treat arrhythmias. But a forward-thinker and frequent inventor, he drives several other practice-changing projects that many electrophysiologists could only dream of. 


Top 10 Update | #1 for 2015: Mobile Stroke Treatment Unit

01/25/2021

Top 10 Update | #1 for 2015: Mobile Stroke Treatment Unit

Strokes occur frequently in the US – once every 40 seconds, to be exact, with an American dying from stroke complications every four minutes. Stroke is now the fifth leading cause of death in this country, and number one in much of the world. Although many people survive a stroke, even multiple episodes, stroke is still the leading cause of disability and thus a care priority at Cleveland Clinic.


COVID-19: Vaccines, Myths, & Masks

01/19/2021

COVID-19: Vaccines, Myths, & Masks

Following Emergency Use Authorization (EUA) from the FDA of COVID-19 vaccines in mid-December, Cleveland Clinic began its distribution of the limited doses received. Vaccinating according to a phased approach, with focus on frontline, inpatient-facing caregivers, the enterprise has worked overtime to distribute vaccines safely, equitably, and transparently while preserving the ability to maintain critical clinical operations.
 


Top 10 for 2021: #1 | Gene Therapy for Hemoglobinopathies

01/13/2021

Top 10 for 2021: #1 | Gene Therapy for Hemoglobinopathies

Living with a condition with no known cure is the devastating reality for those patients suffering from these genetic disorders. Hemoglobin disorders, or hemoglobinopathies, arise when an individual's beta-globin gene is dysfunctional. The most common hemoglobinopathies include sickle cell disease and thalassemia – combined, affecting an estimated 330,000 kids born worldwide every year.


With Bated Breath: Awaiting New Diagnostic Measures for COVID-19

01/12/2021

With Bated Breath: Awaiting New Diagnostic Measures for COVID-19

Leveraging the ability to measure compounds in the breath known as volatile organic compounds, a team at Cleveland Clinic has developed a breath analysis test to capture vapor droplets and indicate the presence of particular compounds for the diagnosis of COVID-19.


Top 10 for 2021: #2 | Novel Drug for Primary Progressive Multiple Sclerosis

01/04/2021

Top 10 for 2021: #2 | Novel Drug for Primary Progressive Multiple Sclerosis

Multiple sclerosis is not a single disease. The majority of patients – around 85% – suffer from relapsing-remitting MS. Which means they may experience disappearing and reappearing symptoms. In contrast, patients suffering from a less common primary progressive multiple sclerosis have a continuously worsening disease from the time of diagnosis.


Year in Review from Innovation at Cleveland Clinic

12/22/2020

Year in Review from Innovation at Cleveland Clinic

Approaching the end of a year with unprecedented twists and turns, we’re sure you’re in no way short of a library of reflection pieces. And though our final 2020 recap might throw another on the pile, as a health organization battling the pandemic first hand, innovating to bring solutions to light, and investing to be the change healthcare needs, we’d be remiss to not share our thoughts with this community – our lessons learned from being, and supporting, the frontline.


Top 10 for 2021: #3 | Smartphone-Connected Pacemaker Devices

12/21/2020

Top 10 for 2021: #3 | Smartphone-Connected Pacemaker Devices

Convenient and accurate, this newest advancement in cardiac medical technology increases the connection between patient and treatment. While millions of people rely on surgically implanted devices like pacemakers to keep them alive, clinical monitoring is critical and, until now, has only been one-sided.


Top 10 for 2021: #4 | New Medication for Cystic Fibrosis

12/18/2020

Top 10 for 2021: #4 | New Medication for Cystic Fibrosis

Passing a hereditary disease to a child is one of a parent's worst fears. Although uncontrollable, one in every 35 Americans, is born with a defective cystic fibrosis, or CF, gene. With CF, mutations in the cystic fibrosis transmembrane conductance regulator, or CFTR gene, cause the CFTR protein to become dysfunctional, making it unable to help move chloride to the surface of the cells in the body.


MIS2020 Recap: Session 4

12/17/2020

MIS2020 Recap: Session 4

Whether you joined us live on October 6, watched content On Demand, or have yet to engage with the 2020 Medical Innovation Summit by Cleveland Clinic, the learning opportunity remains as we continue to host recordings of the live event on our interactive platform. Access to these recordings, however, expires 12/31 – sign in or register today to view them before they’re gone


 <  1 2 3 4 5 6 7 8 9 10  > 

Get In Touch With Us